Can a Pharma Drug Improve Autism Conditions?

Can a Pharma Drug Improve Autism Conditions?

Source: 
BioSpace
snippet: 

There are no treatments for autism, but that’s not stopping research into the development of therapies for core symptoms of autism spectrum disorder. This week, London-based AMO Pharma reported Phase II results from its investigational glycogen synthase kinase 3 (GSK3) beta inhibitor, AMO-02 (tideglusib), which showed patients dosed with the medication during the trial experienced an improvement in social withdrawal, repetitive behaviors, daily living skills, memory and sleep quality.